Experiences with rituximab for the treatment of autoimmune diseases with ocular involvement
Objective. To report the efficacy of rituximab (RTX) in the treatment of ocular or orbital inflammation accompanying autoimmune diseases refractory to previous standard immunosuppressive therapy. - Methods. We reviewed medical records of 9 consecutive patients with noninfectious ocular or orbital in...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2014
|
| In: |
The journal of rheumatology
Year: 2013, Volume: 41, Issue: 1, Pages: 84-90 |
| ISSN: | 1499-2752 |
| DOI: | 10.3899/jrheum.130206 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3899/jrheum.130206 Verlag, lizenzpflichtig, Volltext: https://www.jrheum.org/content/41/1/84 
|
| Author Notes: | Laura Pelegrin, Eva Jakob, Annette Schmidt-Bacher, Vedat Schwenger, Matthias Becker, Regina Max, Hans Martin Lorenz, and Friederike Mackensen |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1737618397 | ||
| 003 | DE-627 | ||
| 005 | 20230426153242.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201103r20142013xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3899/jrheum.130206 |2 doi | |
| 035 | |a (DE-627)1737618397 | ||
| 035 | |a (DE-599)KXP1737618397 | ||
| 035 | |a (OCoLC)1341375452 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Pelegrin, Laura |e VerfasserIn |0 (DE-588)1220707139 |0 (DE-627)1737618885 |4 aut | |
| 245 | 1 | 0 | |a Experiences with rituximab for the treatment of autoimmune diseases with ocular involvement |c Laura Pelegrin, Eva Jakob, Annette Schmidt-Bacher, Vedat Schwenger, Matthias Becker, Regina Max, Hans Martin Lorenz, and Friederike Mackensen |
| 264 | 1 | |c 2014 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First Release: Nov 15, 2013 | ||
| 500 | |a Gesehen am 03.11.2020 | ||
| 520 | |a Objective. To report the efficacy of rituximab (RTX) in the treatment of ocular or orbital inflammation accompanying autoimmune diseases refractory to previous standard immunosuppressive therapy. - Methods. We reviewed medical records of 9 consecutive patients with noninfectious ocular or orbital inflammation treated with RTX. - Results. Over a mean followup of 42 months, 7 patients were in clinical remission, 1 had partial response to treatment, and 1 did not respond. Best corrected visual acuity improved ≥ 1 line in 4 patients, was stable in another 4 patients, and worsened in 1. Concomitant immunosuppressive therapy was tapered in 6 cases. Systemic corticosteroids were tapered or kept below 7.5 mg a day in 5 patients 1 year after the first RTX cycle. - Conclusion. RTX therapy, in patients who are refractory to standard immunosuppressive therapy, was effective and showed a beneficial response to treatment including induction of clinical remission of inflammation in most patients. | ||
| 534 | |c 2013 | ||
| 650 | 4 | |a CLINICAL REMISSION | |
| 650 | 4 | |a GRANULOMATOUS POLYANGIITIS | |
| 650 | 4 | |a OCULAR INFLAMMATION | |
| 650 | 4 | |a ORBITAL INFLAMMATION | |
| 650 | 4 | |a RITUXIMAB | |
| 700 | 1 | |a Jakob, Eva |d 1982- |e VerfasserIn |0 (DE-588)136112323 |0 (DE-627)694090476 |0 (DE-576)284683191 |4 aut | |
| 700 | 1 | |a Schmidt-Bacher, Annette |e VerfasserIn |0 (DE-588)1171144830 |0 (DE-627)1040386024 |0 (DE-576)513606270 |4 aut | |
| 700 | 1 | |a Schwenger, Vedat |e VerfasserIn |0 (DE-588)1022867652 |0 (DE-627)717320197 |0 (DE-576)176592237 |4 aut | |
| 700 | 1 | |a Becker, Matthias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Max, Regina |e VerfasserIn |0 (DE-588)1050991001 |0 (DE-627)785478418 |0 (DE-576)176590609 |4 aut | |
| 700 | 1 | |a Lorenz, Hanns-Martin |d 1962- |e VerfasserIn |0 (DE-588)112253865 |0 (DE-627)627277845 |0 (DE-576)167601369 |4 aut | |
| 700 | 1 | |a Mackensen, Friederike |d 1974-2016 |e VerfasserIn |0 (DE-588)123739594 |0 (DE-627)706412761 |0 (DE-576)29385386X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The journal of rheumatology |d Toronto, Ont. : [Verlag nicht ermittelbar], 2001 |g 41(2014), 1, Seite 84-90 |h Online-Ressource |w (DE-627)325490023 |w (DE-600)2036792-2 |w (DE-576)094529698 |x 1499-2752 |7 nnas |a Experiences with rituximab for the treatment of autoimmune diseases with ocular involvement |
| 773 | 1 | 8 | |g volume:41 |g year:2014 |g number:1 |g pages:84-90 |g extent:7 |a Experiences with rituximab for the treatment of autoimmune diseases with ocular involvement |
| 856 | 4 | 0 | |u https://doi.org/10.3899/jrheum.130206 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.jrheum.org/content/41/1/84 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20201103 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 123739594 |a Mackensen, Friederike |m 123739594:Mackensen, Friederike |d 910000 |d 910900 |d 50000 |e 910000PM123739594 |e 910900PM123739594 |e 50000PM123739594 |k 0/910000/ |k 1/910000/910900/ |k 0/50000/ |p 8 |y j | ||
| 998 | |g 112253865 |a Lorenz, Hanns-Martin |m 112253865:Lorenz, Hanns-Martin |d 910000 |d 910100 |e 910000PL112253865 |e 910100PL112253865 |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 998 | |g 1050991001 |a Max, Regina |m 1050991001:Max, Regina |d 910000 |d 910100 |e 910000PM1050991001 |e 910100PM1050991001 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 1022867652 |a Schwenger, Vedat |m 1022867652:Schwenger, Vedat |d 50000 |e 50000PS1022867652 |k 0/50000/ |p 4 | ||
| 998 | |g 1171144830 |a Schmidt-Bacher, Annette |m 1171144830:Schmidt-Bacher, Annette |p 3 | ||
| 998 | |g 136112323 |a Jakob, Eva |m 136112323:Jakob, Eva |p 2 | ||
| 999 | |a KXP-PPN1737618397 |e 3791520490 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"Experiences with rituximab for the treatment of autoimmune diseases with ocular involvement","title_sort":"Experiences with rituximab for the treatment of autoimmune diseases with ocular involvement"}],"person":[{"role":"aut","given":"Laura","display":"Pelegrin, Laura","family":"Pelegrin"},{"role":"aut","given":"Eva","display":"Jakob, Eva","family":"Jakob"},{"family":"Schmidt-Bacher","display":"Schmidt-Bacher, Annette","given":"Annette","role":"aut"},{"display":"Schwenger, Vedat","family":"Schwenger","given":"Vedat","role":"aut"},{"role":"aut","given":"Matthias","display":"Becker, Matthias","family":"Becker"},{"display":"Max, Regina","family":"Max","given":"Regina","role":"aut"},{"given":"Hanns-Martin","display":"Lorenz, Hanns-Martin","family":"Lorenz","role":"aut"},{"given":"Friederike","display":"Mackensen, Friederike","family":"Mackensen","role":"aut"}],"physDesc":[{"extent":"7 S."}],"relHost":[{"disp":"Experiences with rituximab for the treatment of autoimmune diseases with ocular involvementThe journal of rheumatology","pubHistory":["Nachgewiesen 28.2001 -"],"note":["Gesehen am 12.03.19"],"recId":"325490023","language":["eng"],"id":{"eki":["325490023"],"zdb":["2036792-2"],"issn":["1499-2752"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedDisp":"2001-","publisherPlace":"Toronto, Ont.","publisher":"[Verlag nicht ermittelbar]","dateIssuedKey":"2001"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"The journal of rheumatology","subtitle":"a monthly international peer review journal","title_sort":"journal of rheumatology"}],"part":{"volume":"41","pages":"84-90","text":"41(2014), 1, Seite 84-90","year":"2014","extent":"7","issue":"1"}}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.3899/jrheum.130206"],"eki":["1737618397"]},"language":["eng"],"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"2014"}],"name":{"displayForm":["Laura Pelegrin, Eva Jakob, Annette Schmidt-Bacher, Vedat Schwenger, Matthias Becker, Regina Max, Hans Martin Lorenz, and Friederike Mackensen"]},"recId":"1737618397","note":["First Release: Nov 15, 2013","Gesehen am 03.11.2020"]} | ||
| SRT | |a PELEGRINLAEXPERIENCE2014 | ||